Commissioning

NHS England concludes wide-ranging deal for cystic fibrosis drugs

NHS England has today announced it has secured a definitive agreement with Vertex Pharmaceuticals to make available all three of their UK-licensed cystic fibrosis medicines. This means NHS patients will now have full access to Orkambi, Symkevi and Kalydeco, and around 5000 people may now take up these treatments. There is no cap on patient numbers, and each and every patient in England who […]

Read more

Improved NHS care for Parkinson’s, Multiple Sclerosis and Motor Neurone Disease to save 2,500 hospital trips

People living with brain and nerve conditions like Parkinson’s could benefit from quicker diagnosis and better coordinated care as part of a new NHS initiative, which is also set to free up millions of pounds to reinvest in patient care. NHS experts have joined forces with seven leading charities to produce a toolkit that will […]

Read more

NHS England to fund first ever treatment for children with rare muscle-wasting condition

NHS England will provide a promising new treatment which can prolong the lives of children with a rare genetic condition after negotiating a deal with the manufacturer. Nusinersen, also called Spinraza and made by Biogen, is the first treatment that targets the underlying cause of spinal muscular atrophy (SMA). The condition affects the nerves in […]

Read more

PrEP Impact Trial to be expanded

New places for the PrEP Impact Trial will now start to be released following agreement at the PrEP Oversight Board. Implementation of the PrEP Impact trial has been a huge success with over 11,500 participants already enrolled in this important HIV prevention measure. With the speed of recruitment and need for PrEP significantly exceeding initial […]

Read more

Update on the PrEP Impact Trial

Implementation of the PrEP Impact trial has been a huge success with over 10,000 participants already enrolled in this important HIV prevention measure. But, the speed of recruitment and demand for PrEP has significantly exceeded initial expert predictions and the trial researchers now consider that more places should be made available. They argue that recruitment […]

Read more

NHS England strikes deal for ground breaking cancer treatment in a new European first

Adult cancer patients in England will receive a new game-changing therapy treatment under the first negotiated deal of its kind struck in Europe, NHS England chief executive Simon Stevens announced today. This is the first time adult NHS patients will have access to CAR-T, and follows a deal NHS England reached last month to make […]

Read more